Cellebrite DI announced its half-year 2025 results, reporting revenue of US$220.83 million, a turnaround to net income of US$36.88 million, and the appointment of Thomas E. Hogan as CEO, following his ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Conference call to be held with management on August 25 at 10 am hosted by Craig-Hallum.Webcast Link Published first on TheFly – the ultimate ...

Cellebrite DI ( ($CLBT) ) just unveiled an announcement. On August 15, 2025, Cellebrite DI Ltd. announced its upcoming Annual General Meeting of ...

Cellebrite experienced solid growth in Q2 2025, exceeding expectations for sales and earnings. Signs of a rebound are encouraging.

Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

Earlier this year, Cellebrite DI Ltd. (NASDAQ:CLBT) underwent an independent review and received a FedRAMP High Ready status. Now, with the US Department of Justice as its sponsor, the company ...

Read today's latest Cellebrite (CLBT) share news from our expert in-house team of financial journalists.